Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868308 · ClinicalTrials.gov registry record
Screening To Obviate Preterm Birth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 589
- Enrollment target
NCT01868308: Completed study, sponsored by University of Pennsylvania.
NCT01868308 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 589 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01868308 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 589 participants
- Enrollment target
Study Summary
Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervicovaginal biomarkers associated with cervical remodeling in a prospective cohort of symptomatic women with a singleton pregnancy at high risk for preterm birth in an effort to better risk stratify this cohort.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01868308
The ClinicalTrials.gov registry entry for NCT01868308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 589 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01868308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01868308 about?
NCT01868308 is a clinical study titled "Screening To Obviate Preterm Birth". Our objective is to investigate the predictive value of a panel of biomarkers associated with two biologically plausible pathways of preterm birth: membrane breakdown and cervical remodeling. The investigators will obtain cervical length, cervicovaginal fetal fibronectin, and a panel of novel cervic...
What is the current status of trial NCT01868308?
This trial is currently completed. The enrollment target is 589 participants. The study started on 2013-01. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01868308?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.